Commercial teams: Throw out the rundown

Posted by Kumar Ritwik on Fri, May 22, 2020

Access COVID-19 resources

Amid COVID, pharma commercial teams must operate like primetime TV news crews trying to cover a breaking news story. A production rundown, which is used to orchestrate the live news broadcast on normal days, is of no use when news is breaking live. Similarly, commercial teams have their own playbooks and SOPs and must “throw out the rundown” to plan a way forward.

While the focus over the last couple of months has been on quick wins, such as setting up response teams and situation monitoring hubs, here are three ways that pharma commercial teams can prepare for the next phase:


>
Read More

Discussing Patient Centricity’s Challenges and Opportunities

Posted by Pratap Khedkar on Wed, Jun 21, 2017

In my last blog post, I used the pharmaceutical industry’s quest for patient centricity as a jumping-off point to discuss how pharma companies need to focus on customer centricity, rethinking their commercial strategies to better address their many stakeholders in the evolving healthcare ecosystem. But since patients’ wellness is the pharmaceutical industry’s reason for being, patient centricity should remain pharma’s North Star. 


>
Read More

Three Tips on How to Align Your Sales Comp With Evolving Customer-Facing Roles

Posted by Mike Martin on Fri, Jun 02, 2017

Changes within the healthcare ecosystem—continued M&A activity, the emergence of value-based care, influences within local healthcare markets—are affecting many ways in which biopharmaceutical manufacturers are going to market. Companies are adapting by adding new sales roles, differentiating the types of roles across the nation, co-developing solutions with large providers, and rethinking their sales compensation strategies


>
Read More

How Biopharma Companies Can Adapt to Industry Changes: Step Two

Posted by Jude Konzelmann on Wed, May 17, 2017


Karan Dhundia co-wrote this blog post with Jude Konzelmann.

In our last blog post, we discussed three pressing challenges for commercial organizations within the biopharmaceutical industry: the increasing evolution and (often uneven) consolidation of healthcare customers, the complexity of each geography’s key influencers and how they work together to deliver care in different therapy areas, and stakeholders’ inconsistent definitions of value. To address these challenges, we proposed a four-part transition framework—covering deployment, roles, structure and marketing—and we delved into step one: the reorganization of field-based commercial personnel. Now let’s get to step two.


>
Read More

Big Data Delivers Insights, but Can Your Sales Planners React in Real Time?

Posted by Maria Kliatchko on Thu, Oct 09, 2014

(This blog series introduces emerging trends in sales planning that every commercial operations department must prepare to face in the future.)

Embracing Big Data and unlocking its power with analytics will only take you so far. What happens when months are required to use those insights or react productively? The true endgame involves both systems and internal processes evolving into real-time resource and activity reallocation.


>
Read More